JPMorgan Chase & Co’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.14M | Sell |
1,242,871
-37,379
| -3% | -$64.3K | ﹤0.01% | 3291 |
|
2025
Q1 | $4.26M | Sell |
1,280,250
-26,576
| -2% | -$88.5K | ﹤0.01% | 2774 |
|
2024
Q4 | $9.67M | Sell |
1,306,826
-586,106
| -31% | -$4.34M | ﹤0.01% | 2256 |
|
2024
Q3 | $17.8M | Sell |
1,892,932
-1,545,300
| -45% | -$14.5M | ﹤0.01% | 1784 |
|
2024
Q2 | $27.6M | Sell |
3,438,232
-947,462
| -22% | -$7.6M | ﹤0.01% | 1454 |
|
2024
Q1 | $65M | Buy |
4,385,694
+1,546,027
| +54% | +$22.9M | 0.01% | 1058 |
|
2023
Q4 | $23.1M | Buy |
2,839,667
+93,311
| +3% | +$759K | ﹤0.01% | 1536 |
|
2023
Q3 | $12.5M | Buy |
2,746,356
+111,069
| +4% | +$505K | ﹤0.01% | 1824 |
|
2023
Q2 | $18.6M | Buy |
2,635,287
+565,916
| +27% | +$3.98M | ﹤0.01% | 1594 |
|
2023
Q1 | $12.6M | Sell |
2,069,371
-266,749
| -11% | -$1.63M | ﹤0.01% | 1815 |
|
2022
Q4 | $14.9M | Buy |
2,336,120
+222,842
| +11% | +$1.42M | ﹤0.01% | 1621 |
|
2022
Q3 | $20.2M | Buy |
2,113,278
+71,609
| +4% | +$686K | ﹤0.01% | 1390 |
|
2022
Q2 | $22.5M | Buy |
2,041,669
+187,936
| +10% | +$2.07M | ﹤0.01% | 1360 |
|
2022
Q1 | $30.9M | Sell |
1,853,733
-163,698
| -8% | -$2.73M | ﹤0.01% | 1280 |
|
2021
Q4 | $38.5M | Buy |
2,017,431
+378,695
| +23% | +$7.23M | ﹤0.01% | 1204 |
|
2021
Q3 | $40.4M | Buy |
1,638,736
+223,729
| +16% | +$5.52M | 0.01% | 1167 |
|
2021
Q2 | $36.8M | Buy |
1,415,007
+72,198
| +5% | +$1.88M | ﹤0.01% | 1243 |
|
2021
Q1 | $42.5M | Buy |
1,342,809
+399,796
| +42% | +$12.7M | 0.01% | 1138 |
|
2020
Q4 | $43.8M | Buy |
943,013
+239,541
| +34% | +$11.1M | 0.01% | 1036 |
|
2020
Q3 | $22.7M | Buy |
703,472
+77,093
| +12% | +$2.49M | ﹤0.01% | 1260 |
|
2020
Q2 | $17.2M | Buy |
626,379
+68,222
| +12% | +$1.87M | ﹤0.01% | 1338 |
|
2020
Q1 | $16.7M | Buy |
558,157
+22,395
| +4% | +$670K | ﹤0.01% | 1244 |
|
2019
Q4 | $14.8M | Buy |
535,762
+62,065
| +13% | +$1.72M | ﹤0.01% | 1529 |
|
2019
Q3 | $8.62M | Buy |
473,697
+9,521
| +2% | +$173K | ﹤0.01% | 1881 |
|
2019
Q2 | $10.5M | Buy |
464,176
+19,532
| +4% | +$441K | ﹤0.01% | 1707 |
|
2019
Q1 | $4.23M | Sell |
444,644
-4,725
| -1% | -$44.9K | ﹤0.01% | 2198 |
|
2018
Q4 | $3.98M | Buy |
449,369
+21,137
| +5% | +$187K | ﹤0.01% | 2242 |
|
2018
Q3 | $4.82M | Sell |
428,232
-7,654
| -2% | -$86.1K | ﹤0.01% | 2268 |
|
2018
Q2 | $5.58M | Sell |
435,886
-74,102
| -15% | -$949K | ﹤0.01% | 2187 |
|
2018
Q1 | $8.62M | Sell |
509,988
-754,122
| -60% | -$12.7M | ﹤0.01% | 1857 |
|
2017
Q4 | $10.1M | Sell |
1,264,110
-515,590
| -29% | -$4.12M | ﹤0.01% | 1811 |
|
2017
Q3 | $14.1M | Buy |
1,779,700
+690,527
| +63% | +$5.45M | ﹤0.01% | 1533 |
|
2017
Q2 | $8.01M | Buy |
+1,089,173
| New | +$8.01M | ﹤0.01% | 1848 |
|
2017
Q1 | – | Sell |
-6,575
| Closed | -$46K | – | 4477 |
|
2016
Q4 | $46K | Buy |
+6,575
| New | +$46K | ﹤0.01% | 4045 |
|
2016
Q3 | – | Sell |
-3,246
| Closed | -$26K | – | 4165 |
|
2016
Q2 | $26K | Buy |
3,246
+2,097
| +183% | +$16.8K | ﹤0.01% | 3664 |
|
2016
Q1 | $6K | Buy |
1,149
+774
| +206% | +$4.04K | ﹤0.01% | 3840 |
|
2015
Q4 | $3K | Buy |
+375
| New | +$3K | ﹤0.01% | 3837 |
|